Silken Gran Hotel Havana
Gran Via de les Corts Catalanes 647, 08010
This premier B2B event will enable the participants to learn about the latest developments and provide the appropriate platform for dialogue and networking with peers involved in Pharma Pricing & Market Access.
The Summit will shed light on current Pharma Pricing & Market Access challenges, best practice, new solutions, and trends of today and those we anticipate in the future in Pharma Pricing & Market Access.
At this Summit you will have an unprecedented opportunity to learn from some of the most renowned experts in the field that will enable you to put into practice whta you learnt in the future, resulting in significant advantages that will enable you to overtake your competitors in the market.
Key Practical Learning Points of the Summit:
Who Should Attend:
CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:
From Industries Including:
John Alter VP Global Health & Value Global Established Pharma Business Unit Pfizer
Adam Levysohn Senior Director, Global Market Access Lead – Biosimilars Biogen
Dr. Anne Marciniak Senior Director European HEOR Allergan
Anne-Toni Rodgers Head Global Payer Evidence & Pricing Astrazeneca
Mona Khalid Senior Director Head Evidence & Value Generation Takeda
Klaas Postema Senior Director Market Access & Pricing Generics Europe Actavis
Prof Peter Rutherford MD PhD Vice President Integrated Market Access QuintilesIMS
Bertrand Tardivel Head of Global Pricing Takeda
Oliver Leatham Vice President / Global Head of Pricing & Market Access Parexel
Dražen Jeleč, MD, MBA Market Access Director Roche
Please, complete details below:
Please, complete details below and you will get Agenda via E-mail:
Please, complete details below and you will get 500 € Document Package: